nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—osteoporosis—ankylosing spondylitis	0.351	1	CtDrD
Conjugated Estrogens—breast cancer—Betamethasone—ankylosing spondylitis	0.128	0.5	CpDpCtD
Conjugated Estrogens—breast cancer—Dexamethasone—ankylosing spondylitis	0.128	0.5	CpDpCtD
Conjugated Estrogens—Exemestane—Methylprednisolone—ankylosing spondylitis	0.0506	0.357	CrCrCtD
Conjugated Estrogens—Exemestane—Prednisone—ankylosing spondylitis	0.0462	0.326	CrCrCtD
Conjugated Estrogens—Exemestane—Prednisolone—ankylosing spondylitis	0.0451	0.318	CrCrCtD
Conjugated Estrogens—ABCC11—Methotrexate—ankylosing spondylitis	0.0307	0.145	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—ankylosing spondylitis	0.0211	0.0999	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—ankylosing spondylitis	0.0135	0.0638	CbGbCtD
Conjugated Estrogens—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0109	0.0518	CbGbCtD
Conjugated Estrogens—SLCO1A2—Prednisolone—ankylosing spondylitis	0.00982	0.0464	CbGbCtD
Conjugated Estrogens—ABCC2—Sulfasalazine—ankylosing spondylitis	0.00961	0.0455	CbGbCtD
Conjugated Estrogens—SLCO1A2—Prednisone—ankylosing spondylitis	0.00927	0.0439	CbGbCtD
Conjugated Estrogens—ABCG2—Sulfasalazine—ankylosing spondylitis	0.00869	0.0411	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—ankylosing spondylitis	0.00848	0.0401	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—ankylosing spondylitis	0.00753	0.0356	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—ankylosing spondylitis	0.00696	0.0329	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—ankylosing spondylitis	0.00648	0.0307	CbGbCtD
Conjugated Estrogens—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.00579	0.0274	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—ankylosing spondylitis	0.00521	0.0246	CbGbCtD
Conjugated Estrogens—ABCC2—Dexamethasone—ankylosing spondylitis	0.0048	0.0227	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—ankylosing spondylitis	0.00465	0.022	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—ankylosing spondylitis	0.00439	0.0208	CbGbCtD
Conjugated Estrogens—ABCG2—Dexamethasone—ankylosing spondylitis	0.00434	0.0205	CbGbCtD
Conjugated Estrogens—ABCB1—Methylprednisolone—ankylosing spondylitis	0.00413	0.0196	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—ankylosing spondylitis	0.00405	0.0192	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—ankylosing spondylitis	0.00386	0.0182	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—ankylosing spondylitis	0.00349	0.0165	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—ankylosing spondylitis	0.00282	0.0133	CbGbCtD
Conjugated Estrogens—ABCB1—Betamethasone—ankylosing spondylitis	0.00269	0.0127	CbGbCtD
Conjugated Estrogens—ABCB1—Prednisolone—ankylosing spondylitis	0.00265	0.0126	CbGbCtD
Conjugated Estrogens—ABCB1—Prednisone—ankylosing spondylitis	0.00251	0.0119	CbGbCtD
Conjugated Estrogens—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00248	0.0117	CbGbCtD
Conjugated Estrogens—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00188	0.00888	CbGbCtD
Conjugated Estrogens—CYP3A4—Betamethasone—ankylosing spondylitis	0.00161	0.00762	CbGbCtD
Conjugated Estrogens—CYP3A4—Prednisolone—ankylosing spondylitis	0.00159	0.00752	CbGbCtD
Conjugated Estrogens—ABCB1—Dexamethasone—ankylosing spondylitis	0.00156	0.0074	CbGbCtD
Conjugated Estrogens—CYP3A4—Prednisone—ankylosing spondylitis	0.0015	0.0071	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—ankylosing spondylitis	0.00126	0.00595	CbGbCtD
Conjugated Estrogens—CYP3A4—Dexamethasone—ankylosing spondylitis	0.000937	0.00443	CbGbCtD
Conjugated Estrogens—Cough—Triamcinolone—ankylosing spondylitis	4.25e-05	0.00107	CcSEcCtD
Conjugated Estrogens—Convulsion—Triamcinolone—ankylosing spondylitis	4.22e-05	0.00106	CcSEcCtD
Conjugated Estrogens—Tachycardia—Prednisolone—ankylosing spondylitis	4.22e-05	0.00106	CcSEcCtD
Conjugated Estrogens—Convulsion—Methylprednisolone—ankylosing spondylitis	4.21e-05	0.00106	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Prednisolone—ankylosing spondylitis	4.18e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Myalgia—Triamcinolone—ankylosing spondylitis	4.15e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Myalgia—Methylprednisolone—ankylosing spondylitis	4.14e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methylprednisolone—ankylosing spondylitis	4.14e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Eye disorder—Prednisone—ankylosing spondylitis	4.14e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Anxiety—Methylprednisolone—ankylosing spondylitis	4.13e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Infestation—Methotrexate—ankylosing spondylitis	4.12e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Methotrexate—ankylosing spondylitis	4.12e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	4.11e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Depression—Methotrexate—ankylosing spondylitis	4.11e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Renal failure—Methotrexate—ankylosing spondylitis	4.05e-05	0.00102	CcSEcCtD
Conjugated Estrogens—Angioedema—Betamethasone—ankylosing spondylitis	4.04e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Angioedema—Dexamethasone—ankylosing spondylitis	4.04e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Angiopathy—Prednisone—ankylosing spondylitis	4.02e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Prednisone—ankylosing spondylitis	4e-05	0.001	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	3.98e-05	0.000999	CcSEcCtD
Conjugated Estrogens—Oedema—Triamcinolone—ankylosing spondylitis	3.98e-05	0.000999	CcSEcCtD
Conjugated Estrogens—Vertigo—Betamethasone—ankylosing spondylitis	3.97e-05	0.000998	CcSEcCtD
Conjugated Estrogens—Vertigo—Dexamethasone—ankylosing spondylitis	3.97e-05	0.000998	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	3.97e-05	0.000997	CcSEcCtD
Conjugated Estrogens—Syncope—Betamethasone—ankylosing spondylitis	3.97e-05	0.000996	CcSEcCtD
Conjugated Estrogens—Syncope—Dexamethasone—ankylosing spondylitis	3.97e-05	0.000996	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Prednisone—ankylosing spondylitis	3.95e-05	0.000992	CcSEcCtD
Conjugated Estrogens—Infection—Triamcinolone—ankylosing spondylitis	3.95e-05	0.000992	CcSEcCtD
Conjugated Estrogens—Infection—Methylprednisolone—ankylosing spondylitis	3.94e-05	0.00099	CcSEcCtD
Conjugated Estrogens—Shock—Triamcinolone—ankylosing spondylitis	3.91e-05	0.000983	CcSEcCtD
Conjugated Estrogens—Insomnia—Prednisolone—ankylosing spondylitis	3.91e-05	0.000982	CcSEcCtD
Conjugated Estrogens—Alopecia—Prednisone—ankylosing spondylitis	3.91e-05	0.000982	CcSEcCtD
Conjugated Estrogens—Shock—Methylprednisolone—ankylosing spondylitis	3.91e-05	0.000981	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	3.9e-05	0.000978	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	3.89e-05	0.000977	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Dexamethasone—ankylosing spondylitis	3.89e-05	0.000976	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Betamethasone—ankylosing spondylitis	3.89e-05	0.000976	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Prednisolone—ankylosing spondylitis	3.89e-05	0.000975	CcSEcCtD
Conjugated Estrogens—Tachycardia—Triamcinolone—ankylosing spondylitis	3.88e-05	0.000975	CcSEcCtD
Conjugated Estrogens—Mental disorder—Prednisone—ankylosing spondylitis	3.88e-05	0.000973	CcSEcCtD
Conjugated Estrogens—Tachycardia—Methylprednisolone—ankylosing spondylitis	3.87e-05	0.000973	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methylprednisolone—ankylosing spondylitis	3.86e-05	0.000968	CcSEcCtD
Conjugated Estrogens—Erythema—Prednisone—ankylosing spondylitis	3.85e-05	0.000967	CcSEcCtD
Conjugated Estrogens—Malnutrition—Prednisone—ankylosing spondylitis	3.85e-05	0.000967	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	3.85e-05	0.000966	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	3.84e-05	0.000963	CcSEcCtD
Conjugated Estrogens—Convulsion—Betamethasone—ankylosing spondylitis	3.83e-05	0.000962	CcSEcCtD
Conjugated Estrogens—Convulsion—Dexamethasone—ankylosing spondylitis	3.83e-05	0.000962	CcSEcCtD
Conjugated Estrogens—Myalgia—Betamethasone—ankylosing spondylitis	3.77e-05	0.000945	CcSEcCtD
Conjugated Estrogens—Myalgia—Dexamethasone—ankylosing spondylitis	3.77e-05	0.000945	CcSEcCtD
Conjugated Estrogens—Anxiety—Dexamethasone—ankylosing spondylitis	3.75e-05	0.000942	CcSEcCtD
Conjugated Estrogens—Anxiety—Betamethasone—ankylosing spondylitis	3.75e-05	0.000942	CcSEcCtD
Conjugated Estrogens—Hypotension—Methylprednisolone—ankylosing spondylitis	3.71e-05	0.000931	CcSEcCtD
Conjugated Estrogens—Pain—Prednisolone—ankylosing spondylitis	3.7e-05	0.000929	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—ankylosing spondylitis	3.67e-05	0.000922	CcSEcCtD
Conjugated Estrogens—Vision blurred—Prednisone—ankylosing spondylitis	3.63e-05	0.000911	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	3.63e-05	0.00091	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	3.62e-05	0.000908	CcSEcCtD
Conjugated Estrogens—Oedema—Dexamethasone—ankylosing spondylitis	3.61e-05	0.000906	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	3.61e-05	0.000906	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Betamethasone—ankylosing spondylitis	3.61e-05	0.000906	CcSEcCtD
Conjugated Estrogens—Oedema—Betamethasone—ankylosing spondylitis	3.61e-05	0.000906	CcSEcCtD
Conjugated Estrogens—Insomnia—Triamcinolone—ankylosing spondylitis	3.6e-05	0.000903	CcSEcCtD
Conjugated Estrogens—Insomnia—Methylprednisolone—ankylosing spondylitis	3.59e-05	0.000901	CcSEcCtD
Conjugated Estrogens—Infection—Betamethasone—ankylosing spondylitis	3.59e-05	0.0009	CcSEcCtD
Conjugated Estrogens—Infection—Dexamethasone—ankylosing spondylitis	3.59e-05	0.0009	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Triamcinolone—ankylosing spondylitis	3.57e-05	0.000897	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methylprednisolone—ankylosing spondylitis	3.56e-05	0.000895	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—ankylosing spondylitis	3.56e-05	0.000895	CcSEcCtD
Conjugated Estrogens—Shock—Dexamethasone—ankylosing spondylitis	3.55e-05	0.000892	CcSEcCtD
Conjugated Estrogens—Shock—Betamethasone—ankylosing spondylitis	3.55e-05	0.000892	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Triamcinolone—ankylosing spondylitis	3.55e-05	0.000891	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Dexamethasone—ankylosing spondylitis	3.54e-05	0.000889	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Betamethasone—ankylosing spondylitis	3.54e-05	0.000889	CcSEcCtD
Conjugated Estrogens—Tachycardia—Dexamethasone—ankylosing spondylitis	3.52e-05	0.000885	CcSEcCtD
Conjugated Estrogens—Tachycardia—Betamethasone—ankylosing spondylitis	3.52e-05	0.000885	CcSEcCtD
Conjugated Estrogens—Angioedema—Prednisone—ankylosing spondylitis	3.52e-05	0.000884	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Triamcinolone—ankylosing spondylitis	3.5e-05	0.000879	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—ankylosing spondylitis	3.5e-05	0.000878	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methylprednisolone—ankylosing spondylitis	3.49e-05	0.000877	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	3.49e-05	0.000876	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Betamethasone—ankylosing spondylitis	3.49e-05	0.000876	CcSEcCtD
Conjugated Estrogens—Vertigo—Prednisone—ankylosing spondylitis	3.46e-05	0.000869	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—ankylosing spondylitis	3.46e-05	0.000868	CcSEcCtD
Conjugated Estrogens—Syncope—Prednisone—ankylosing spondylitis	3.45e-05	0.000867	CcSEcCtD
Conjugated Estrogens—Anorexia—Betamethasone—ankylosing spondylitis	3.44e-05	0.000864	CcSEcCtD
Conjugated Estrogens—Anorexia—Dexamethasone—ankylosing spondylitis	3.44e-05	0.000864	CcSEcCtD
Conjugated Estrogens—Urticaria—Prednisolone—ankylosing spondylitis	3.44e-05	0.000863	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—ankylosing spondylitis	3.43e-05	0.000862	CcSEcCtD
Conjugated Estrogens—Fatigue—Triamcinolone—ankylosing spondylitis	3.43e-05	0.000861	CcSEcCtD
Conjugated Estrogens—Fatigue—Methylprednisolone—ankylosing spondylitis	3.42e-05	0.000859	CcSEcCtD
Conjugated Estrogens—Pain—Triamcinolone—ankylosing spondylitis	3.4e-05	0.000854	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Prednisone—ankylosing spondylitis	3.39e-05	0.00085	CcSEcCtD
Conjugated Estrogens—Hypotension—Dexamethasone—ankylosing spondylitis	3.37e-05	0.000847	CcSEcCtD
Conjugated Estrogens—Hypotension—Betamethasone—ankylosing spondylitis	3.37e-05	0.000847	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—ankylosing spondylitis	3.36e-05	0.000842	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—ankylosing spondylitis	3.34e-05	0.000839	CcSEcCtD
Conjugated Estrogens—Convulsion—Prednisone—ankylosing spondylitis	3.34e-05	0.000838	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—ankylosing spondylitis	3.33e-05	0.000837	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	3.29e-05	0.000826	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	3.29e-05	0.000826	CcSEcCtD
Conjugated Estrogens—Myalgia—Prednisone—ankylosing spondylitis	3.28e-05	0.000823	CcSEcCtD
Conjugated Estrogens—Arthralgia—Prednisone—ankylosing spondylitis	3.28e-05	0.000823	CcSEcCtD
Conjugated Estrogens—Anxiety—Prednisone—ankylosing spondylitis	3.27e-05	0.000821	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—ankylosing spondylitis	3.27e-05	0.00082	CcSEcCtD
Conjugated Estrogens—Insomnia—Betamethasone—ankylosing spondylitis	3.27e-05	0.00082	CcSEcCtD
Conjugated Estrogens—Insomnia—Dexamethasone—ankylosing spondylitis	3.27e-05	0.00082	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	3.26e-05	0.000818	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	3.25e-05	0.000815	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Dexamethasone—ankylosing spondylitis	3.24e-05	0.000814	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Betamethasone—ankylosing spondylitis	3.24e-05	0.000814	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—ankylosing spondylitis	3.24e-05	0.000813	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—ankylosing spondylitis	3.22e-05	0.000808	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—ankylosing spondylitis	3.22e-05	0.000808	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Prednisolone—ankylosing spondylitis	3.19e-05	0.0008	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Dexamethasone—ankylosing spondylitis	3.18e-05	0.000798	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Betamethasone—ankylosing spondylitis	3.18e-05	0.000798	CcSEcCtD
Conjugated Estrogens—Urticaria—Triamcinolone—ankylosing spondylitis	3.16e-05	0.000794	CcSEcCtD
Conjugated Estrogens—Urticaria—Methylprednisolone—ankylosing spondylitis	3.15e-05	0.000792	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—ankylosing spondylitis	3.15e-05	0.000791	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Triamcinolone—ankylosing spondylitis	3.15e-05	0.00079	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Prednisone—ankylosing spondylitis	3.14e-05	0.000789	CcSEcCtD
Conjugated Estrogens—Oedema—Prednisone—ankylosing spondylitis	3.14e-05	0.000789	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methylprednisolone—ankylosing spondylitis	3.14e-05	0.000788	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Betamethasone—ankylosing spondylitis	3.14e-05	0.000788	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Dexamethasone—ankylosing spondylitis	3.14e-05	0.000788	CcSEcCtD
Conjugated Estrogens—Infection—Prednisone—ankylosing spondylitis	3.12e-05	0.000784	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	3.12e-05	0.000782	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	3.12e-05	0.000782	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—ankylosing spondylitis	3.11e-05	0.000782	CcSEcCtD
Conjugated Estrogens—Fatigue—Betamethasone—ankylosing spondylitis	3.11e-05	0.000781	CcSEcCtD
Conjugated Estrogens—Fatigue—Dexamethasone—ankylosing spondylitis	3.11e-05	0.000781	CcSEcCtD
Conjugated Estrogens—Shock—Prednisone—ankylosing spondylitis	3.09e-05	0.000777	CcSEcCtD
Conjugated Estrogens—Pain—Betamethasone—ankylosing spondylitis	3.09e-05	0.000775	CcSEcCtD
Conjugated Estrogens—Pain—Dexamethasone—ankylosing spondylitis	3.09e-05	0.000775	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Prednisone—ankylosing spondylitis	3.08e-05	0.000774	CcSEcCtD
Conjugated Estrogens—Tachycardia—Prednisone—ankylosing spondylitis	3.07e-05	0.00077	CcSEcCtD
Conjugated Estrogens—Skin disorder—Prednisone—ankylosing spondylitis	3.05e-05	0.000767	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Prednisone—ankylosing spondylitis	3.04e-05	0.000763	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—ankylosing spondylitis	3.03e-05	0.000762	CcSEcCtD
Conjugated Estrogens—Anorexia—Prednisone—ankylosing spondylitis	3e-05	0.000752	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	2.95e-05	0.000741	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	2.95e-05	0.000741	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.93e-05	0.000736	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.92e-05	0.000734	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—ankylosing spondylitis	2.89e-05	0.000726	CcSEcCtD
Conjugated Estrogens—Urticaria—Dexamethasone—ankylosing spondylitis	2.87e-05	0.00072	CcSEcCtD
Conjugated Estrogens—Urticaria—Betamethasone—ankylosing spondylitis	2.87e-05	0.00072	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	2.86e-05	0.000719	CcSEcCtD
Conjugated Estrogens—Dizziness—Prednisolone—ankylosing spondylitis	2.86e-05	0.000718	CcSEcCtD
Conjugated Estrogens—Asthenia—Triamcinolone—ankylosing spondylitis	2.85e-05	0.000717	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Betamethasone—ankylosing spondylitis	2.85e-05	0.000716	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Dexamethasone—ankylosing spondylitis	2.85e-05	0.000716	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Dexamethasone—ankylosing spondylitis	2.85e-05	0.000716	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Betamethasone—ankylosing spondylitis	2.85e-05	0.000716	CcSEcCtD
Conjugated Estrogens—Asthenia—Methylprednisolone—ankylosing spondylitis	2.85e-05	0.000715	CcSEcCtD
Conjugated Estrogens—Insomnia—Prednisone—ankylosing spondylitis	2.84e-05	0.000714	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Prednisone—ankylosing spondylitis	2.82e-05	0.000709	CcSEcCtD
Conjugated Estrogens—Pruritus—Triamcinolone—ankylosing spondylitis	2.82e-05	0.000707	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—ankylosing spondylitis	2.81e-05	0.000705	CcSEcCtD
Conjugated Estrogens—Pruritus—Methylprednisolone—ankylosing spondylitis	2.81e-05	0.000705	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—ankylosing spondylitis	2.79e-05	0.0007	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Prednisone—ankylosing spondylitis	2.77e-05	0.000695	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—ankylosing spondylitis	2.74e-05	0.000688	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—ankylosing spondylitis	2.74e-05	0.000688	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—ankylosing spondylitis	2.74e-05	0.000688	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Prednisone—ankylosing spondylitis	2.73e-05	0.000686	CcSEcCtD
Conjugated Estrogens—Rash—Prednisolone—ankylosing spondylitis	2.73e-05	0.000685	CcSEcCtD
Conjugated Estrogens—Dermatitis—Prednisolone—ankylosing spondylitis	2.73e-05	0.000684	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.72e-05	0.000683	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.72e-05	0.000682	CcSEcCtD
Conjugated Estrogens—Fatigue—Prednisone—ankylosing spondylitis	2.71e-05	0.00068	CcSEcCtD
Conjugated Estrogens—Headache—Prednisolone—ankylosing spondylitis	2.71e-05	0.00068	CcSEcCtD
Conjugated Estrogens—Constipation—Prednisone—ankylosing spondylitis	2.69e-05	0.000675	CcSEcCtD
Conjugated Estrogens—Dizziness—Triamcinolone—ankylosing spondylitis	2.63e-05	0.000661	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—ankylosing spondylitis	2.63e-05	0.00066	CcSEcCtD
Conjugated Estrogens—Dizziness—Methylprednisolone—ankylosing spondylitis	2.63e-05	0.000659	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—ankylosing spondylitis	2.61e-05	0.000655	CcSEcCtD
Conjugated Estrogens—Asthenia—Betamethasone—ankylosing spondylitis	2.59e-05	0.00065	CcSEcCtD
Conjugated Estrogens—Asthenia—Dexamethasone—ankylosing spondylitis	2.59e-05	0.00065	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—ankylosing spondylitis	2.58e-05	0.000647	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.57e-05	0.000645	CcSEcCtD
Conjugated Estrogens—Nausea—Prednisolone—ankylosing spondylitis	2.57e-05	0.000645	CcSEcCtD
Conjugated Estrogens—Pruritus—Betamethasone—ankylosing spondylitis	2.55e-05	0.000641	CcSEcCtD
Conjugated Estrogens—Pruritus—Dexamethasone—ankylosing spondylitis	2.55e-05	0.000641	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—ankylosing spondylitis	2.55e-05	0.000641	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—ankylosing spondylitis	2.54e-05	0.000638	CcSEcCtD
Conjugated Estrogens—Vomiting—Triamcinolone—ankylosing spondylitis	2.53e-05	0.000635	CcSEcCtD
Conjugated Estrogens—Vomiting—Methylprednisolone—ankylosing spondylitis	2.52e-05	0.000634	CcSEcCtD
Conjugated Estrogens—Rash—Triamcinolone—ankylosing spondylitis	2.51e-05	0.00063	CcSEcCtD
Conjugated Estrogens—Dermatitis—Triamcinolone—ankylosing spondylitis	2.51e-05	0.000629	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—ankylosing spondylitis	2.5e-05	0.000629	CcSEcCtD
Conjugated Estrogens—Rash—Methylprednisolone—ankylosing spondylitis	2.5e-05	0.000628	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.5e-05	0.000628	CcSEcCtD
Conjugated Estrogens—Urticaria—Prednisone—ankylosing spondylitis	2.5e-05	0.000627	CcSEcCtD
Conjugated Estrogens—Headache—Triamcinolone—ankylosing spondylitis	2.49e-05	0.000626	CcSEcCtD
Conjugated Estrogens—Headache—Methylprednisolone—ankylosing spondylitis	2.49e-05	0.000624	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Prednisone—ankylosing spondylitis	2.49e-05	0.000624	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Prednisone—ankylosing spondylitis	2.49e-05	0.000624	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Dexamethasone—ankylosing spondylitis	2.47e-05	0.00062	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Betamethasone—ankylosing spondylitis	2.47e-05	0.00062	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—ankylosing spondylitis	2.46e-05	0.000616	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	2.39e-05	0.000601	CcSEcCtD
Conjugated Estrogens—Dizziness—Betamethasone—ankylosing spondylitis	2.39e-05	0.000599	CcSEcCtD
Conjugated Estrogens—Dizziness—Dexamethasone—ankylosing spondylitis	2.39e-05	0.000599	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—ankylosing spondylitis	2.38e-05	0.000597	CcSEcCtD
Conjugated Estrogens—Nausea—Triamcinolone—ankylosing spondylitis	2.36e-05	0.000593	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—ankylosing spondylitis	2.36e-05	0.000592	CcSEcCtD
Conjugated Estrogens—Nausea—Methylprednisolone—ankylosing spondylitis	2.36e-05	0.000592	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—ankylosing spondylitis	2.34e-05	0.000588	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—ankylosing spondylitis	2.34e-05	0.000586	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Prednisone—ankylosing spondylitis	2.32e-05	0.000582	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—ankylosing spondylitis	2.31e-05	0.000581	CcSEcCtD
Conjugated Estrogens—Vomiting—Dexamethasone—ankylosing spondylitis	2.3e-05	0.000576	CcSEcCtD
Conjugated Estrogens—Vomiting—Betamethasone—ankylosing spondylitis	2.3e-05	0.000576	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—ankylosing spondylitis	2.28e-05	0.000573	CcSEcCtD
Conjugated Estrogens—Rash—Betamethasone—ankylosing spondylitis	2.28e-05	0.000571	CcSEcCtD
Conjugated Estrogens—Rash—Dexamethasone—ankylosing spondylitis	2.28e-05	0.000571	CcSEcCtD
Conjugated Estrogens—Dermatitis—Betamethasone—ankylosing spondylitis	2.27e-05	0.000571	CcSEcCtD
Conjugated Estrogens—Dermatitis—Dexamethasone—ankylosing spondylitis	2.27e-05	0.000571	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	2.27e-05	0.000569	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—ankylosing spondylitis	2.27e-05	0.000569	CcSEcCtD
Conjugated Estrogens—Headache—Dexamethasone—ankylosing spondylitis	2.26e-05	0.000568	CcSEcCtD
Conjugated Estrogens—Headache—Betamethasone—ankylosing spondylitis	2.26e-05	0.000568	CcSEcCtD
Conjugated Estrogens—Asthenia—Prednisone—ankylosing spondylitis	2.26e-05	0.000566	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—ankylosing spondylitis	2.25e-05	0.000564	CcSEcCtD
Conjugated Estrogens—Pruritus—Prednisone—ankylosing spondylitis	2.22e-05	0.000558	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Prednisone—ankylosing spondylitis	2.15e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	2.15e-05	0.000539	CcSEcCtD
Conjugated Estrogens—Nausea—Betamethasone—ankylosing spondylitis	2.14e-05	0.000538	CcSEcCtD
Conjugated Estrogens—Nausea—Dexamethasone—ankylosing spondylitis	2.14e-05	0.000538	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—ankylosing spondylitis	2.09e-05	0.000524	CcSEcCtD
Conjugated Estrogens—Dizziness—Prednisone—ankylosing spondylitis	2.08e-05	0.000522	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—ankylosing spondylitis	2.08e-05	0.000521	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—ankylosing spondylitis	2.08e-05	0.000521	CcSEcCtD
Conjugated Estrogens—Vomiting—Prednisone—ankylosing spondylitis	2e-05	0.000502	CcSEcCtD
Conjugated Estrogens—Rash—Prednisone—ankylosing spondylitis	1.98e-05	0.000498	CcSEcCtD
Conjugated Estrogens—Dermatitis—Prednisone—ankylosing spondylitis	1.98e-05	0.000497	CcSEcCtD
Conjugated Estrogens—Headache—Prednisone—ankylosing spondylitis	1.97e-05	0.000494	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.94e-05	0.000486	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—ankylosing spondylitis	1.89e-05	0.000473	CcSEcCtD
Conjugated Estrogens—Nausea—Prednisone—ankylosing spondylitis	1.87e-05	0.000469	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—ankylosing spondylitis	1.86e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—ankylosing spondylitis	1.8e-05	0.000451	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—ankylosing spondylitis	1.74e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—ankylosing spondylitis	1.67e-05	0.000419	CcSEcCtD
Conjugated Estrogens—Rash—Methotrexate—ankylosing spondylitis	1.66e-05	0.000416	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—ankylosing spondylitis	1.66e-05	0.000416	CcSEcCtD
Conjugated Estrogens—Headache—Methotrexate—ankylosing spondylitis	1.65e-05	0.000413	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—ankylosing spondylitis	1.56e-05	0.000392	CcSEcCtD
